Olivo Alicia C 4
4 · NEOGENOMICS INC · Filed May 13, 2026
Research Summary
AI-generated summary of this filing
NEOGENOMICS (NEO) EVP Alicia Olivo Exercises/Converts Derivative; Shares Withheld
What Happened
- Alicia C. Olivo, EVP, General Counsel & Head of Business Development at Neogenomics (NEO), had 3,944 derivative shares reported as exercised/converted on May 11, 2026 (transaction code M). The filing also shows 2,559 shares disposed to satisfy tax withholding (transaction code F), leaving a net 1,385 shares delivered to her. All entries report $0.00 per share (these were conversions/settlements, not cash purchases or market sales).
- The filing lists both an acquisition entry (3,944 shares acquired on conversion) and disposition entries for tax withholding (2,559) and a derivative disposition (3,944). The practical effect reported is issuance/settlement of shares with a portion withheld for taxes.
Key Details
- Transaction date: May 11, 2026; Form 4 filed May 13, 2026 (appears filed within the standard reporting window).
- Prices reported: $0.00 — reflects conversion/settlement rather than an open-market purchase/sale.
- Gross shares converted: 3,944; shares withheld for taxes: 2,559; net shares delivered: 1,385.
- Transaction codes: M = exercise/conversion of derivative; F = payment of exercise price or tax liability (share withholding).
- Shares owned after transaction: not specified in the Form 4 summary provided.
- Relevant footnotes: the filing references multiple equity grants over prior years (including grants dated May 11, 2023 and grants in 2024–2026). Some awards vest ratably and some are performance-based; the conversion likely relates to previously granted awards that vested or were settled.
Context
- This was a conversion/settlement event (derivative exercise/vesting) with shares withheld to cover tax obligations — a routine administrative occurrence rather than an open-market purchase or sale that signals a trading view.
- For retail investors: purchases are generally more informative as a bullish signal. Here, the net result is Ms. Olivo received 1,385 shares after withholding; no cash proceeds or open-market sale proceeds were reported.
Insider Transaction Report
Form 4
Olivo Alicia C
EVP, GC & Business Development
Transactions
- Exercise/Conversion
Common Stock
2026-05-11+3,944→ 96,126 total - Tax Payment
Common Stock
2026-05-11−2,559→ 93,567 total - Exercise/Conversion
Restricted Stock Unit
[F1][F2]2026-05-11−3,944→ 2,559 totalExercise: $0.00→ Common Stock (3,944 underlying)
Holdings
- 1,046
Stock Option (Right to Buy)
[F3]Exercise: $19.12Exp: 2026-09-30→ Common Stock (1,046 underlying) - 1,024
Stock Option (Right to Buy)
[F4]Exercise: $27.34Exp: 2027-05-01→ Common Stock (1,024 underlying) - 516
Stock Option (Right to Buy)
[F5]Exercise: $48.99Exp: 2028-05-01→ Common Stock (516 underlying) - 1,117
Stock Option (Right to Buy)
[F6]Exercise: $46.10Exp: 2028-08-01→ Common Stock (1,117 underlying) - 22,222
Stock Option (Right to Buy)
[F7]Exercise: $9.45Exp: 2029-05-01→ Common Stock (22,222 underlying) - 46,355
Stock Option (Right to Buy)
[F8]Exercise: $10.05Exp: 2029-09-01→ Common Stock (46,355 underlying) - 36,508
Stock Option (Right to Buy)
[F9]Exercise: $19.65Exp: 2030-05-11→ Common Stock (36,508 underlying) - 19,508
Performance Stock Unit
[F10][F2]Exercise: $0.00From: 2026-05-11→ Common Stock (19,508 underlying) - 42,344
Stock Option (Right to Buy)
[F11]Exercise: $16.45Exp: 2034-02-23→ Common Stock (42,344 underlying) - 25,330
Performance Stock Unit
[F12][F2]Exercise: $0.00From: 2027-02-23→ Common Stock (25,330 underlying) - 8,443
Restricted Stock Unit
[F13][F2]Exercise: $0.00→ Common Stock (8,443 underlying) - 59,382
Restricted Stock Unit
[F2]Exercise: $0.00From: 2026-01-13→ Common Stock (59,382 underlying) - 107,450
Stock Option (Right to Buy)
[F14][F15]Exercise: $13.05Exp: 2035-02-21→ Common Stock (107,450 underlying) - 42,159
Restricted Stock Unit
[F16][F2]Exercise: $0.00→ Common Stock (42,159 underlying) - 147,804
Stock Option (Right to Buy)
[F17][F18]Exercise: $10.81Exp: 2036-03-01→ Common Stock (147,804 underlying) - 89,013
Restricted Stock Unit
[F19][F2]Exercise: $0.00→ Common Stock (89,013 underlying)
Footnotes (19)
- [F1]On May 11, 2023, Ms. Olivo was granted 19,508 restricted stock units. The restricted stock units vest ratably over the first three anniversary dates of the grant date.
- [F10]On May 11, 2023, Ms. Olivo was granted 19,508 performance stock units representing the number of shares that may vest at target performance. The maximum number of shares that may vest pursuant to the performance criteria is 29,262. The number of performance stock units that may vest is based on the achievement of certain share growth goals based on the weighted average price of the Company's common stock over the 20-day trailing trading period at theapplicable measurement dates, subject to continued service with the Company.
- [F11]On February 23, 2024, Ms. Olivo was granted 42,344 stock options. The options vest ratably over the first three anniversary dates of the grant date.
- [F12]On February 23, 2024, Ms. Olivo was granted 25,330 performance stock units representing the number of shares that may vest at target performance. The maximum number of shares that may vest pursuant to the performance criteria is37,996. 50% of the number of performance stock units that may vest is based on the achievement of certain share growth goals based on the weighted average price of the Company's common stock over the 20-day trailing trading period atthe applicable measurement dates, subject to continued service with the Company. 50% of the number of performance stock units that may vest is based on the achievement of certain revenue growth goals based on the achievement of thecumulative fiscal year revenue goal at the applicable measurement amounts, subject to continued service with the Company.
- [F13]On February 23, 2024, Ms. Olivo was granted 25,329 restricted stock units. The restricted stock units vest ratably over the first three anniversary dates of the grant date.
- [F14]This stock option was granted as a premium-price stock option. To calculate the premium exercise price we used the closing price on February 20, 2025 and multiplied by 110%.
- [F15]On February 21, 2025, Ms. Olivo was granted 107,450 stock options. The options vest ratably over the first three anniversary dates of the grant date.
- [F16]On February 21, 2025, Ms. Olivo was granted 63,238 restricted stock units. The restricted stock units vest ratably over the first three anniversary dates of the grant date.
- [F17]This stock option was granted as a premium-price stock option. To calculate the premium exercise price we used the closing price on February 27, 2026 and multiplied by 110%.
- [F18]On March 1, 2026, Ms. Olivo was granted 147,804 stock options. The options vest ratably over the first three anniversary dates of the grant date.
- [F19]On March 1, 2026, Ms. Olivo was granted 89,013 restricted stock units. The restricted stock units vest ratably over the first three anniversary dates of the grant date.
- [F2]Once vested, the shares of common stock are not subject to expiration.
- [F3]On September 30, 2019, Ms. Olivo was granted 1,394 stock options. The options vest ratably over the first four anniversary dates of the grant date.
- [F4]On May 1, 2020, Ms. Olivo was granted 1,024 stock options. The options vest ratably over the first four anniversary dates of the grant date.
- [F5]On May 1, 2021, Ms. Olivo was granted 516 stock options. The options vest ratably over the first four anniversary dates of the grant date.
- [F6]On August 1, 2021, Ms. Olivo was granted 1,117 stock options. The options vest ratably over the first four anniversary dates of the grant date.
- [F7]On May 1, 2022, Ms. Olivo was granted 22,222 stock options. The options vest ratably over the first four anniversary dates of the grant date.
- [F8]On September 1, 2022, Ms. Olivo was granted 55,332 stock options. The options vest ratably over the first four anniversary dates of the grant date.
- [F9]On May 11, 2023, Ms. Olivo was granted 36,508 stock options. The options vest ratably over the first three anniversary dates of the grant date.
Signature
/s/ Alicia C. Olivo|2026-05-13